Nosocomial infection in patients with lung cancer during chemotherapy: A clinical investigation
DOI:
Author:
Affiliation:

Clc Number:

R734.2

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    ObjectiveTo investigate the characteristics of nosocomial infection (NI) in patients with lung cancer treated by chemotherapy. MethodsA retrospective analysis on clinical data of 2 067 patients with lung cancer from January, 2003 to December ,2007 was made. ResultsThe NI rate in patients with lung cancer treated by chemotherapy was 7.93%. Upper respiratory tract infection and  lower respiratory tract infection was 51.11% and 33.89% respectively. Patients’ characteristics, including average hospital stay, average chemotherapy cycles, the degree of leukopenia and application of granulocyte colony stimulating factors were not obviously different between patients  with  and without NI (all P>0.05). NI rate increased significantly in patients with grade Ⅲ or Ⅳ leukopenia (P=0.000), but there was no difference in NI rate between patients receiving and not receiving preventive antimicrobial agents (both P>0.05).ConclusionThe most common NI in patients with lung cancer during chemotherapy are upper respiratory tract infection and   lower respiratory tract infection. Taking antimicrobial agents as a preventive measure against infection seems to have no effect on decreasing  NI rate in patients with grade Ⅲ or Ⅳ leukopenia.

    Reference
    Related
Get Citation

王伟,陈平,谭建明,等.肺癌化疗患者医院感染临床分析[J].中国感染控制杂志英文版,2008,7(6):392-395.
WANG Wei, CHEN Ping, TAN Jianming, et al. Nosocomial infection in patients with lung cancer during chemotherapy: A clinical investigation[J]. Chin J Infect Control, 2008,7(6):392-395.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 18,2008
  • Revised:July 02,2008
  • Adopted:
  • Online: November 30,2008
  • Published: